Online citations, reference lists, and bibliographies.
← Back to Search

Treatment Of Focal Hyperhidrosis With Botulinum Toxin Type A: Long‐term Follow‐up In 61 Patients

P. Schnider, E. Moraru, H. Kittler, Michael Binder, G. Kranz, B. Voller, E. Auff
Published 2001 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background The blocking action of botulinum toxin type A (BTX‐A) on cholinergically innervated sweat glands has been used successfully to treat patients with focal hyperhidrosis.
This paper references
10.1046/j.1365-2133.1999.02769.x
A randomized, double‐blind, placebo‐controlled trial of botulinum A toxin for severe axillary hyperhidrosis
Schnider (1999)
10.1212/WNL.45.9.1743
Response and immunoresistance to botulinum toxin injections
J. Jankovic (1995)
10.3109/00016489509139348
Frey's syndrome: treatment with botulinum toxin.
C. Drobik (1995)
10.1212/WNL.43.9.1715
Botulinum antibodies in dystonic patients treated with type A botulinum toxin
M. Zuber (1993)
10.1016/S0190-9622(98)70242-7
Botulinum toxin therapy for palmar hyperhidrosis.
W. Shelley (1998)
Axillary hyperhidrosis. Local treatment with aluminium-chloride hexahydrate 25% in absolute ethanol with and without supplementary treatment with triethanolamine.
L. Glent-Madsen (1988)
10.1016/S0140-6736(05)62730-4
Uses of botulinum toxin
N. Girdler (1997)
10.1001/ARCHDERM.134.3.301
Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin.
M. Naumann (1998)
[Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
P. Schnider (1999)
10.1046/j.1365-2133.1997.d01-1233.x
Double‐blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms
P. Schnider (1997)
10.1111/j.1365-2230.1996.tb00093.x
Botulinum toxin–a possible new treatment for axillary hyperhidrosis
K. Bushara (1996)
10.1002/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
M. Brin (1997)
10.1302/0301-620X.40B3.454
Objective methods for determining the functional value of sensibility in the hand.
E. Moberg (1958)
General and clinical aspects of treatment with botulinum toxin
P. Moore (1995)
10.1016/S0190-9622(98)70297-X
Botulinum toxin in the treatment of palmar hyperhidrosis.
S. Holmes (1998)
10.1111/j.1468-1331.1999.tb00028.x
Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience
H. Naver (1999)
[Different types of nerve injuries in locoregional anesthesia].
S. Hernot (1997)
Die Botulinumtoxin - behandlung : Vom gefuÈ rchteteten biologischen Toxin zum Standardmedikament
P Schnider (1999)
10.1016/S0190-9622(99)70258-6
Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis.
M. Heckmann (1999)
10.1007/BF00862976
Dystrophin deficiency in a case of congenital myopathy
A. Prelle (2004)
[Treatment of spasmodic torticollis with local injections of botulinum toxin A].
F. Erbguth (1991)
10.1016/S0750-7658(97)89844-9
Neurostimulation sous anesthésie générale et traumatisme nerveux périphérique
O. Choquet (1997)



This paper is referenced by
10.2336/NISHINIHONHIFU.65.599
Experiences of Botulinum Toxin Type A in the Treatment of Palmar and Plantar Hyperhidrosis
Y. Murakami (2003)
10.1001/ARCHDERM.142.3.320
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
B. Rzany (2006)
10.1016/J.ANNDER.2014.11.005
Prise en charge d’une hyperhidrose
H. Maillard (2015)
10.1111/j.1365-2133.2005.06921.x
Five cases of cutaneous leishmaniasis in Cambridge, U.K.
W. Loo (2005)
10.1016/J.JAAD.2005.07.017
Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis.
G. Kavanagh (2006)
10.1111/j.1365-2133.2009.09248.x
Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogenous acetylcholine
M. Shibasaki (2009)
10.1001/ARCHDERM.141.10.1255
Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
M. Heckmann (2005)
nguinal , or Hexsel ’ s Hyperhidrosis ÓRIS
MARIA HEXSEL (2004)
10.1046/J.1524-4725.2003.29122.X
Prospective Open‐Label Study of Botulinum Toxin Type B (Myobloc) at Doses of 2,400 and 3,000 U for the Treatment of Glabellar Wrinkles
N. Sadick (2003)
10.1016/S1047-9651(03)00095-0
Treatment of hyperhidrosis and drooling with botulinum exotoxin.
I. Odderson (2003)
10.1046/j.1365-2133.2001.04362.x
Chronic glomerulonephritis remarkably improved after surgery for acne conglobata of the buttocks
Y. Shimomura (2001)
10.1001/ARCHDERM.139.6.731
Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
M. Naumann (2003)
10.1590/S0004-282X2005000200006
Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.
L. Silveira-Moriyama (2005)
10.1016/S0246-0319(04)41821-4
Reconnaissance, diagnostic et traitement de l'hyperhidrose primaire localisée*
B. J. Hornbergera (2006)
10.1002/9780470750520.CH45
Disorders of Sweat Glands
I. Coulson (2008)
10.1046/j.1365-2133.2001.04368.x
Xanthogranuloma is the archetype of non‐Langerhans cell histiocytoses: reply from author
A. C. Chu (2001)
Schweißbehandlung mit Botulinumtoxin: Die fokale Hyperhidrose als autonome Indikation
Bernhard Voller (2010)
Guidelines on the use of botulinum toxin type A.
M. K. Shetty (2008)
10.1157/13072970
Empleo terapéutico de la toxina botulínica
P. Olasolo (2005)
10.1046/j.1365-2133.2001.04367.x
Xanthogranuloma is the archetype of non‐Langerhans cell histiocytoses
B. Zelger (2001)
10.1016/S0149-2918(03)90041-5
Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
A. Campanati (2003)
10.1111/j.1473-2165.2005.00304.x
Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience
A. Pérez-Bernal (2005)
10.1046/j.1365-2133.2001.04364.x
Angiolymphoid hyperplasia with eosinophilia in the oral mucosa
H. Tsuboi (2001)
10.1111/j.1524-4725.2009.01390.x
Botulinum Toxin Type A for the Treatment of Glabellar Lines in Chinese: A Double‐Blind, Randomized, Placebo‐Controlled Study
Y. Wu (2010)
La toxine botulique A : intérêt thérapeutique dans l‘hyperhidrose et dans les suites d‘une amputation
P. Foucault (2003)
10.1111/J.1524-4725.2004.30382.X
A Case of Foul Genital Odor Treated with Botulinum Toxin A
Jae-Bong Lee (2004)
10.3310/hta21800
Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis.
R. Wade (2017)
10.1111/j.1365-2133.2005.06916.x
Delivery of Botox® by iontophoresis: reply from authors
G. Kavanagh (2005)
10.1016/J.JAAD.2003.12.029
Recognition, diagnosis, and treatment of primary focal hyperhidrosis.
J. Hornberger (2004)
10.1111/ddg.12623
Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: A retrospective analysis in 101 patients
F. Brehmer (2015)
10.1016/S0213-9251(02)72595-1
Uso de la toxina botulínica en dermatología, ¿todo son éxitos?
P. Olasolo (2002)
10.1111/ijd.12625
Generalized neurological symptoms following treatment of focal hyperhidrosis with botulinum toxin A
A. Kouris (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar